WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010113179) PROCESS FOR PURIFYING ESLICARBAZEPINE ACETATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/113179    International Application No.:    PCT/IN2010/000207
Publication Date: 07.10.2010 International Filing Date: 30.03.2010
IPC:
C07D 223/28 (2006.01), C07D 223/24 (2006.01), A61K 31/55 (2006.01), A61P 25/08 (2006.01)
Applicants: GLENMARK GENERICS LIMITED [IN/IN]; Glenmark House HDO-Corporate Bldg, Wing-A B.D.Sawant Marg, Chakala Andheri (East) Mumbai 400099 (IN) (For All Designated States Except US).
KOILPILLAI, Joseph Prabahar [IN/IN]; (IN) (For US Only).
KULKARNI, Pravin Bhalchandra [IN/IN]; (IN) (For US Only).
SAWANT, Sachin Bapurao [IN/IN]; (IN) (For US Only).
LIMBEKAR, Nagesh Devidasrao [IN/IN]; (IN) (For US Only)
Inventors: KOILPILLAI, Joseph Prabahar; (IN).
KULKARNI, Pravin Bhalchandra; (IN).
SAWANT, Sachin Bapurao; (IN).
LIMBEKAR, Nagesh Devidasrao; (IN)
Priority Data:
903/MUM/2009 02.04.2009 IN
1860/MUM/2009 12.08.2009 IN
Title (EN) PROCESS FOR PURIFYING ESLICARBAZEPINE ACETATE
(FR) PROCÉDÉ DE PURIFICATION DE L'ACÉTATE D'ESLICARBAZÉPINE
Abstract: front page image
(EN)A process for purifying eslicarbazepine acetate is provided The crystalline particles of eslicarbazepine acetate having a median particle size between 5 μm and 20 μm and a specific surface area of from 0.1 m2/g to 10 m2/g as measured by B.E.T. method are obtained Eslicarbazepine acetate having purity greater than 99.0% as measured by high performance liquid chromatography and a pharmaceutical composition containing the same are also provided.
(FR)La présente invention concerne la purification et la taille particulaire de l'acétate d'eslicarbazépine. L'invention concerne également les caractéristiques physiques de l'acétate d'eslicarbazépine à l'état solide, et des compositions pharmaceutiques le contenant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)